MedPath

HOSPITAL GENERAL DE NIÑOS "PEDRO DE ELIZALDE"

🇦🇷Argentina
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

15

Active:1
Completed:9

Trial Phases

3 Phases

Phase 3:1
Phase 4:3
Not Applicable:8

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Not Applicable
8 (66.7%)
Phase 4
3 (25.0%)
Phase 3
1 (8.3%)

Validation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis.

Active, not recruiting
Conditions
Amyloidosis in Transthyretin (TTR)
Hereditary Amyloidosis, Transthyretin-Related
First Posted Date
2025-07-23
Last Posted Date
2025-07-23
Lead Sponsor
Hospital General de Niños Pedro de Elizalde
Target Recruit Count
70
Registration Number
NCT07080268
Locations
🇦🇷

HGNPE, Buenos Aires, Argentina

Non-attendance Prediction Models to Pediatric Outpatient Appointments

Completed
Conditions
Non-Attendance, Patient
No-Show Patients
First Posted Date
2023-10-11
Last Posted Date
2023-11-08
Lead Sponsor
Hospital General de Niños Pedro de Elizalde
Target Recruit Count
300000
Registration Number
NCT06077630

Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies

Phase 4
Recruiting
Conditions
Uric Acid Nephropathy
Interventions
First Posted Date
2022-06-02
Last Posted Date
2022-11-28
Lead Sponsor
Hospital General de Niños Pedro de Elizalde
Target Recruit Count
40
Registration Number
NCT05402397
Locations
🇦🇷

HGNPE, Caba, Argentina

Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital

Completed
Conditions
Telehealth
First Posted Date
2021-02-03
Last Posted Date
2021-09-22
Lead Sponsor
Hospital General de Niños Pedro de Elizalde
Target Recruit Count
3339
Registration Number
NCT04736680
Locations
🇦🇷

Hospital General de Niños Pedro de Elizalde, Buenos Aires, Argentina

Erythropoietin in Hemolytic Uremic Syndrome

Phase 4
Completed
Conditions
Hemolytic-Uremic Syndrome
Anemia
Interventions
First Posted Date
2018-12-17
Last Posted Date
2021-01-13
Lead Sponsor
Hospital General de Niños Pedro de Elizalde
Target Recruit Count
24
Registration Number
NCT03776851
Locations
🇦🇷

HGNPE, Caba, Argentina

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.